Research Dynamics
26
Mar

2024

CPH – Event Update

CPH Chemie + Papier Holding AG (CPH) announces plan to separate Paper business from Chemistry and Packaging activities

– Deal Overview
– Deal Rationale
– Focus on high growth and superior margin business
– Strategic focus and prospects for Perlen Industrieholding AG post-separation
– Valuation and conclusion

23
Feb

2024

CPH – FY2023 Results

Resilient performance amidst challenges

– Segmental performance
– Outlook for FY2024
– Valuation and conclusion

29
Sep

2023

CPH-Investor Day Update

FY 2023 targets reaffirmed amidst uncertain markets and focus on implementation of sustainability strategy

– Investor Day summary
– Sustainability
– Other highlights
– Valuation and conclusion

24
Jul

2023

CPH – HY2023 Results

Mixed performance amid challenging market    

– Profitability remains intact
– Outlook for FY2023e
– Valuation and conclusion

27
Feb

2023

CPH – FY2022 Results

Broad-based growth across all divisions   

– Elevated levels of profitability  
– Outlook for FY2023
– Valuation and conclusion

17
Nov

2022

CPH – Event Update

Strong volumes and higher realizations lifts CPH’s profitability

– FY2022 guidance raised again with group EBIT guided above CHF 100 million

– Valuation and conclusion

16
Sep

2022

CPH-Investor Day Update

Rising demand for products in the Chemistry division to drive future growth  

  • Chemistry division to provide the next leg of growth
  • Structural megatrends to drive long-term growth
  • Broad-based revenue growth across all divisions in 1H2022
  • Valuation and conclusion

26
Jul

2022

CPH – HY2022 Results

Broad-based growth across all divisions 

– Better volumes and realizations of price increases lift profitability
– Segmental performance
– Cautious outlook for FY2022
– Valuation and conclusion

    

16
Jun

2022

CPH – Event Update

Recovery in all divisions led by higher price realization

  • Profit guidance raised for FY2022
  • Valuation and conclusion

24
Feb

2022

CPH – FY2021 Results

Recovery in all divisions to drive overall growth    

  • The top-line performance was weighed by impairment charges    
  • Segmental performance
  • Encouraging outlook for FY2022
  • Valuation and conclusion